AbCellera gains on antibody collaboration with Biogen (NASDAQ:ABCL) Markets March 11, 2024 [ad_1] Love Worker AbCellera Biologics (NASDAQ:ABCL) is up ~3% in Monday buying and selling after saying a collaboration with Biogen…
